HEADER SUGAR BINDING PROTEIN/ANTIBIOTIC 09-JAN-12 3VFK TITLE THE STRUCTURE OF MONODECHLORO-TEICOPLANIN IN COMPLEX WITH ITS LIGAND, TITLE 2 USING UBIQUITIN AS A LIGAND CARRIER COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN, C-TERMINAL FUSED BY CYS-LYS-D-ALA-D-ALA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: UBIQUITIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: MONODECHLORO- TEICOPLANIN A2-2; COMPND 8 CHAIN: G SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: UBC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: ACTINOPLANES TEICHOMYCETICUS; SOURCE 10 ORGANISM_TAXID: 1867 KEYWDS TEICOPLANIN, ACETYLATION OF CYTEINE WITH IODOACETATE MODIFICATION, KEYWDS 2 SUGAR BINDING PROTEIN-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.J.ECONOMOU,S.D.WEEKS,K.C.GRASTY,P.J.LOLL REVDAT 8 06-DEC-23 3VFK 1 LINK REVDAT 7 27-SEP-23 3VFK 1 SEQRES REVDAT 6 13-SEP-23 3VFK 1 HETSYN REVDAT 5 29-JUL-20 3VFK 1 COMPND REMARK SEQRES HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 19-JUN-13 3VFK 1 JRNL REVDAT 3 03-APR-13 3VFK 1 REMARK SITE REVDAT 2 27-MAR-13 3VFK 1 LINK REMARK SITE HETATM REVDAT 2 2 1 JRNL REVDAT 1 09-JAN-13 3VFK 0 JRNL AUTH N.J.ECONOMOU,I.J.ZENTNER,E.LAZO,J.JAKONCIC,V.STOJANOFF, JRNL AUTH 2 S.D.WEEKS,K.C.GRASTY,S.COCKLIN,P.J.LOLL JRNL TITL STRUCTURE OF THE COMPLEX BETWEEN TEICOPLANIN AND A BACTERIAL JRNL TITL 2 CELL-WALL PEPTIDE: USE OF A CARRIER-PROTEIN APPROACH. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 69 520 2013 JRNL REFN ISSN 0907-4449 JRNL PMID 23519660 JRNL DOI 10.1107/S0907444912050469 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.2_432) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.29 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.040 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 2084 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.279 REMARK 3 R VALUE (WORKING SET) : 0.278 REMARK 3 FREE R VALUE : 0.306 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.460 REMARK 3 FREE R VALUE TEST SET COUNT : 93 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.30 REMARK 3 SHRINKAGE RADIUS : 0.00 REMARK 3 K_SOL : 0.42 REMARK 3 B_SOL : 77.33 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.450 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.930 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.41590 REMARK 3 B22 (A**2) : -20.26010 REMARK 3 B33 (A**2) : 11.84420 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -18.73150 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 777 REMARK 3 ANGLE : 0.847 1061 REMARK 3 CHIRALITY : 0.037 122 REMARK 3 PLANARITY : 0.004 132 REMARK 3 DIHEDRAL : 12.765 318 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3VFK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000069982. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : CRYOGENICALLY-COOLED SINGLE REMARK 200 CRYSTAL SI(111)SIDE BOUNCE REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 2084 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 19.294 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1UBQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MAGNESIUM CHLORIDE, 0.1 M SODIUM REMARK 280 ACETATE 4.6, 18% PEG 1500, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K, PH 4.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.00500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 12.59000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.00500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 12.59000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 AUTHORS STATED THE FOLLOWING: THE STARTING MATERIAL HAD TEICOPLANIN REMARK 400 A2-2 THAT CONTAINED TWO CHLORINE ATOMS. THE ACTUAL CRYSTALS REMARK 400 CONTAINED BOTH CHLORINE ATOMS BEFORE THEY WERE EXPOSED TO X-RAYS. REMARK 400 ONE CHLORINE WAS REMOVED FROM TEICOPLANIN BY X-IRRADIATION DAMAGE REMARK 400 EARLY IN THE DIFFRACTION EXPERIMENT TEICOPLANIN IS A FAMILY OF REMARK 400 TETRACYCLIC GLYCOPEPTIDE ANTIBIOTICS. THE SCAFFOLD IS A REMARK 400 HEPTAPEPTIDE FURTHER GLYCOSYLATED BY THREE MONO SACCHARIDES: REMARK 400 MANNOSE, N-ACETYLGLUCOSAMINE AND BETA-D-GLUCOSAMINE AND ONLY DIFFER REMARK 400 BY THE SIDE CHAIN ATTACHED TO THE LATTER. TEICOPLANIN A2-2 HAS 8- REMARK 400 METHYLNONANOIC ACID ATTACHED TO GLUCOSAMINE. HERE, TEICOPLANIN A2-2 REMARK 400 WAS UNDER RADIATION DAMAGE, WHICH CAUSES THE LOSS OF ONE CHLORINE REMARK 400 ATOM. REMARK 400 REMARK 400 THE MONODECHLORO- TEICOPLANIN A2-2 IS GLYCOPEPTIDE, A MEMBER OF REMARK 400 ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: MONODECHLORO- TEICOPLANIN A2-2 REMARK 400 CHAIN: G REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE GCS REMARK 400 COMPONENT_3: RESIDUE MAN REMARK 400 COMPONENT_4: RESIDUE NAG REMARK 400 COMPONENT_5: RESIDUE T55 REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 54 127.86 -175.15 REMARK 500 3FG G 3 -67.54 -143.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JW4 RELATED DB: PDB REMARK 900 NATIVE MBP STRUCTURE USED FOR MOLECULAR REPLACEMENT REMARK 900 RELATED ID: 3RUN RELATED DB: PDB REMARK 900 SAME CRYSTALLOGRAPHIC STRATEGY: VANCOMYCIN BOUND TO A T4 LYSOZYME- REMARK 900 SUBSTRATE FUSION REMARK 900 RELATED ID: 3RUL RELATED DB: PDB REMARK 900 SAME CRYSTALLOGRAPHIC STRATEGY: DALBAVANCIN BOUND TO THE SAME REMARK 900 UBIQUITIN FUSION REMARK 900 RELATED ID: 3RUM RELATED DB: PDB REMARK 900 SAME CRYSTALLOGRAPHIC STRATEGY: RISTOCETIN BOUND TO A MBP-SUBSTRATE REMARK 900 FUSION REMARK 900 RELATED ID: 3VFJ RELATED DB: PDB REMARK 900 THE STRUCTURE OF MONODECHLORO-TEICOPLANIN IN COMPLEX WITH ITS REMARK 900 LIGAND, USING MBP AS A LIGAND REMARK 999 REMARK 999 SEQUENCE REMARK 999 C-TERMINAL FUSED BY MODIFIED CYS-LYS-D-ALA-D-ALA DBREF 3VFK A 1 75 UNP P0CG48 UBC_HUMAN 1 75 DBREF 3VFK G 1 7 PDB 3VFK 3VFK 1 7 SEQADV 3VFK CCS A 76 UNP P0CG48 SEE REMARK 999 SEQADV 3VFK LYS A 77 UNP P0CG48 SEE REMARK 999 SEQADV 3VFK DAL A 78 UNP P0CG48 SEE REMARK 999 SEQADV 3VFK DAL A 79 UNP P0CG48 SEE REMARK 999 SEQRES 1 A 79 MET GLN ILE PHE VAL LYS THR LEU THR GLY LYS THR ILE SEQRES 2 A 79 THR LEU GLU VAL GLU PRO SER ASP THR ILE GLU ASN VAL SEQRES 3 A 79 LYS ALA LYS ILE GLN ASP LYS GLU GLY ILE PRO PRO ASP SEQRES 4 A 79 GLN GLN ARG LEU ILE PHE ALA GLY LYS GLN LEU GLU ASP SEQRES 5 A 79 GLY ARG THR LEU SER ASP TYR ASN ILE GLN LYS GLU SER SEQRES 6 A 79 THR LEU HIS LEU VAL LEU ARG LEU ARG GLY CCS LYS DAL SEQRES 7 A 79 DAL SEQRES 1 G 7 GHP 3MY 3FG GHP GHP OMX 3FG HET CCS A 76 10 HET DAL A 78 5 HET DAL A 79 6 HET GHP G 1 11 HET 3MY G 2 13 HET 3FG G 3 12 HET GHP G 4 11 HET GHP G 5 11 HET OMX G 6 13 HET 3FG G 7 13 HET GCS G 8 11 HET T55 G 9 11 HET NAG G 10 14 HET MAN G 11 11 HETNAM CCS CARBOXYMETHYLATED CYSTEINE HETNAM DAL D-ALANINE HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM 3MY 3-CHLORO-D-TYROSINE HETNAM 3FG (2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC ACID HETNAM OMX (BETAR)-BETA-HYDROXY-L-TYROSINE HETNAM GCS 2-AMINO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM T55 8-METHYLNONANOIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN GCS BETA-D-GLUCOSAMINE; 2-AMINO-2-DEOXY-BETA-D-GLUCOSE; 2- HETSYN 2 GCS AMINO-2-DEOXY-D-GLUCOSE; 2-AMINO-2-DEOXY-GLUCOSE; D- HETSYN 3 GCS GLUCOSAMINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 1 CCS C5 H9 N O4 S FORMUL 1 DAL 2(C3 H7 N O2) FORMUL 2 GHP 3(C8 H9 N O3) FORMUL 2 3MY C9 H10 CL N O3 FORMUL 2 3FG 2(C8 H9 N O4) FORMUL 2 OMX C9 H11 N O4 FORMUL 3 GCS C6 H13 N O5 FORMUL 4 T55 C10 H20 O2 FORMUL 5 NAG C8 H15 N O6 FORMUL 6 MAN C6 H12 O6 FORMUL 7 HOH *10(H2 O) HELIX 1 1 THR A 22 GLU A 34 1 13 HELIX 2 2 PRO A 37 ASP A 39 5 3 HELIX 3 3 LEU A 56 ASN A 60 5 5 SHEET 1 A 5 ILE A 13 GLU A 16 0 SHEET 2 A 5 GLN A 2 THR A 7 -1 N ILE A 3 O LEU A 15 SHEET 3 A 5 SER A 65 LEU A 71 1 O LEU A 67 N PHE A 4 SHEET 4 A 5 GLN A 41 PHE A 45 -1 N ILE A 44 O HIS A 68 SHEET 5 A 5 LYS A 48 GLN A 49 -1 O LYS A 48 N PHE A 45 LINK C GLY A 75 N CCS A 76 1555 1555 1.32 LINK C CCS A 76 N LYS A 77 1555 1555 1.33 LINK C LYS A 77 N DAL A 78 1555 1555 1.33 LINK C DAL A 78 N DAL A 79 1555 1555 1.33 LINK C GHP G 1 N 3MY G 2 1555 1555 1.33 LINK C5 GHP G 1 OD1 3FG G 3 1555 1555 1.36 LINK C 3MY G 2 N 3FG G 3 1555 1555 1.33 LINK OBD 3MY G 2 C3 GHP G 4 1555 1555 1.38 LINK C 3FG G 3 N GHP G 4 1555 1555 1.33 LINK C GHP G 4 N GHP G 5 1555 1555 1.33 LINK C5 GHP G 4 OH OMX G 6 1555 1555 1.38 LINK O4 GHP G 4 C1 GCS G 8 1555 1555 1.38 LINK C GHP G 5 N OMX G 6 1555 1555 1.33 LINK C3 GHP G 5 CG1 3FG G 7 1555 1555 1.40 LINK C OMX G 6 N 3FG G 7 1555 1555 1.33 LINK OC OMX G 6 C1 NAG G 10 1555 1555 1.38 LINK OD1 3FG G 7 C1 MAN G 11 1555 1555 1.42 LINK N2 GCS G 8 C T55 G 9 1555 1555 1.46 CISPEP 1 GHP G 5 OMX G 6 0 1.18 CRYST1 88.010 25.180 38.710 90.00 109.18 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011362 0.000000 0.003952 0.00000 SCALE2 0.000000 0.039714 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027351 0.00000